Logo

    Alloimmune Thrombocytopenia in the Fetus and Newborn

    enNovember 23, 2022
    What was the main topic of the podcast episode?
    Summarise the key points discussed in the episode?
    Were there any notable quotes or insights from the speakers?
    Which popular books were mentioned in this episode?
    Were there any points particularly controversial or thought-provoking discussed in the episode?
    Were any current events or trending topics addressed in the episode?

    About this Episode

    Host: Lee P. Shulman, MD, FACMG, FACOG
    Guest: James B. Bussel, MD

    This program is no longer available for credit.

    Program Chairman:
    Roberto Romero, MD, DMedSci
    Chief, Perinatology Research Branch
    Division of Maternal-Fetal Medicine and Obstetrics
    Division of Intramural Research
    NICHD/NIH/DHHS
    Editor-in-Chief for Obstetrics
    The American Journal of Obstetrics and Gynecology

    As the platelet equivalent of hemolytic disease of the fetus and newborn, fetal and neonatal alloimmune thrombocytopenia (FNAIT) is an uncommon yet complex and life-threatening bleeding disorder that results from incompatibility between mother and baby for platelet-specific antigens. Despite relatively normal platelet function, in the setting of severe thrombocytopenia, intracranial hemorrhage is a consequence. Drs. Shulman and Bussel discuss advances in management strategies and concrete steps you can take to lower the risk and stop the progression of this disorder in your patients.

    Recent Episodes from Omnia Education

    Patient-Centric Approaches to Managing Migraines in the Female Patient

    Patient-Centric Approaches to Managing Migraines in the Female Patient
    Host: Jessica Ailani, MD
    Guest: Dawn C. Buse, PhD

    Half of the women in the US with migraine are never diagnosed. Of those who are, the journey to effective treatment may last a decade or longer. But newer and more effective targeted treatments are beginning to make a difference. Join Drs. Jessica Ailani and Dawn Buse as they discuss a novel approach to managing migraine and interview a patient whose migraine journey is unfortunately one traversed by many women.

    Patient-Centric Management of Menopausal Symptoms: Improving Outcomes with Individualized Therapy

    Patient-Centric Management of Menopausal Symptoms: Improving Outcomes with Individualized Therapy
    Host: Anita L. Nelson, MD
    Guest: Barbara Dehn, Np, FAANP, NCMP

    Understanding the physiologic basis for the vasomotor symptoms of perimenopause/menopause has led to an improved ability to match a therapeutic approach to each individual patient. New and improved agents are helping to facilitate this dynamic. Join Anita Nelson, MD, and Barbara Dehn, NP, as they provide insights into making the right treatment decision for each patient—one that includes ensuring patient preferences are considered.

    Migraine and Women's Health: Migraine and the Whole Female Patient

    Migraine and Women's Health: Migraine and the Whole Female Patient
    Host: Jessica Ailani, MD
    Guest: Dawn C. Buse, PhD

    Upwards of 47 million people in the U.S. suffer from migraines, often accompanied by widespread personal, professional, and social disabilities. Though a similar prevalence is initially observed between men and women, by mid-adulthood the prevalence of migraine is 3-fold greater in women than men. Newer agents, both injectable and oral and focused on modulating the calcitonin gene-related peptide pathway, have emerged and have proven highly effective in managing both acute and chronic migraine. Join Drs. Jessica Ailani and Dawn Buse as they provide an overview of the changing landscape of migraine therapy, especially as it impacts women across different life-stages.

    Postpartum Depression: A Significant Burden and a Novel Approach to Treatment

    Postpartum Depression: A Significant Burden and a Novel Approach to Treatment
    Host: Lee Shulman MD, FACOG, FACMG
    Guest: Kristina Deligiannidis, MD

    The recent development and approval of two neuroactive steroids is likely to change the treatment paradigm for moderate to severe postpartum depression (PPD). These agents have a quick onset and function as GABAA positive allosteric modulators. Join Drs. Shulman and Deligiannidis as they address the burdens and impacts of PPD on mothers, babies, and partners, and deep dive into the pathophysiologic role and clinical findings associated with the use of neuroactive steroids in the management of PPD.

    Case of the Patient in Midlife: Weighing Potential Changes in ASCCP Guidelines

    Case of the Patient in Midlife: Weighing Potential Changes in ASCCP Guidelines
    Host: Warner K. Huh, MD
    Guest: Sarah E. Dilley, MD, MPH, FACOG

    Effective triage tests are needed to lessen diagnostic uncertainty when assessing cervical cancer risk and selecting which patients will move on to colposcopy. An FDA-approved dual-staining cytology test is available that can help in decision-making for a wide range of patients. Join Drs. Warner Huh and Sarah Dilley as they address current 2019 ASCCP guidelines and anticipate potential updates to ASCCP’s guidance in 2023.

    The Impact and Importance of Iron Status

    The Impact and Importance of Iron Status
    Host: Malcolm G. Munro MD, FRCS(c), FACOG
    Guest: Michael Auerbach, MD

    This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.

    Assessing and Addressing ID/IDA: The Need for Guidance

    Assessing and Addressing ID/IDA: The Need for Guidance
    Host: Malcolm G. Munro MD, FRCS(c), FACOG
    Guest: Arjeme Denise Cavens, MD

    This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.

    Pathogenesis of ID and IDA in Reproductive-Aged Women: Focus on Heavy Menstrual Bleeding

    Pathogenesis of ID and IDA in Reproductive-Aged Women: Focus on Heavy Menstrual Bleeding
    Host: Malcolm G. Munro MD, FRCS(c), FACOG
    Guest: Arjeme Denise Cavens, MD

    This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.

    Contributors to Iron Status: Serum Ferritin, TSAT, and Hemoglobin

    Contributors to Iron Status: Serum Ferritin, TSAT, and Hemoglobin
    Host: Malcolm G. Munro MD, FRCS(c), FACOG
    Guest: Michael Auerbach, MD

    This series of bite-sized episodes contains important information you need to know about iron deficiency and iron deficiency anemia in your female patients. Dr. Malcolm Munro and colleagues discuss recent evidence and provide practical approaches for screening, diagnosing, treating, and preventing the progression of this condition.

    Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection

    Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
    Host: Lee P. Shulman, MD, FACMG, FACOG
    Guest: Roberto Romero, MD, DMedSci

    Renowned international expert Dr. Roberto Romero joins Dr. Lee Shulman to walk us through maternal anti-fetal rejection. Find out about its pathophysiology, mechanisms of disease, approach to diagnosis, and potential treatment so that you can broaden your understanding and improve the care you provide.

    Logo

    © 2024 Podcastworld. All rights reserved

    Stay up to date

    For any inquiries, please email us at hello@podcastworld.io